Archive - WJSAM Finance Hub

Atlantic International Corp (ATLN) Net Loss Narrows amid Cost Reduction and Efficiency Initiatives

Atlantic International Corp (ATLN) Net Loss Narrows amid Cost Reduction and Efficiency Initiatives

Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progress in Product Pipeline Development

Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progress in Product Pipeline Development

Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progress in Product Pipeline Development

Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progress in Product Pipeline Development

JPMorgan Upgrades GAP Airports (PAC) to Overweight, Cuts Target to 460 Mexican Pesos

JPMorgan Upgrades GAP Airports (PAC) to Overweight, Cuts Target to 460 Mexican Pesos

JPMorgan Upgrades GAP Airports (PAC) to Overweight, Cuts Target to 460 Mexican Pesos

JPMorgan Upgrades GAP Airports (PAC) to Overweight, Cuts Target to 460 Mexican Pesos

Barclays Cuts FEMSA (FMX) Target to $105, Keeps Equal Weight Rating

Barclays Cuts FEMSA (FMX) Target to $105, Keeps Equal Weight Rating

Barclays Cuts FEMSA (FMX) Target to $105, Keeps Equal Weight Rating

Barclays Cuts FEMSA (FMX) Target to $105, Keeps Equal Weight Rating

H.C. Wainwright Asserts Buy Rating on Immunitybio Inc. (IBRX) as Net Loss Narrows on Robust Product Revenue

H.C. Wainwright Asserts Buy Rating on Immunitybio Inc. (IBRX) as Net Loss Narrows on Robust Product Revenue

H.C. Wainwright Asserts Buy Rating on Immunitybio Inc. (IBRX) as Net Loss Narrows on Robust Product Revenue

H.C. Wainwright Asserts Buy Rating on Immunitybio Inc. (IBRX) as Net Loss Narrows on Robust Product Revenue

NextNRG Inc. (NXXT) in a Phase of Robust Growth amid Geographic Expansion

NextNRG Inc. (NXXT) in a Phase of Robust Growth amid Geographic Expansion

Latest

Atlantic International Corp (ATLN) Net Loss Narrows amid Cost Reduction and Efficiency Initiatives

Atlantic International Corp (ATLN) Net Loss Narrow...

3 months ago 35

Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progress in Product Pipeline Development

Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progres...

3 months ago 32

Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progress in Product Pipeline Development

Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progres...

3 months ago 33

JPMorgan Upgrades GAP Airports (PAC) to Overweight, Cuts Target to 460 Mexican Pesos

JPMorgan Upgrades GAP Airports (PAC) to Overweight...

3 months ago 45

JPMorgan Upgrades GAP Airports (PAC) to Overweight, Cuts Target to 460 Mexican Pesos

JPMorgan Upgrades GAP Airports (PAC) to Overweight...

3 months ago 36

Barclays Cuts FEMSA (FMX) Target to $105, Keeps Equal Weight Rating

Barclays Cuts FEMSA (FMX) Target to $105, Keeps Eq...

3 months ago 48

Barclays Cuts FEMSA (FMX) Target to $105, Keeps Equal Weight Rating

Barclays Cuts FEMSA (FMX) Target to $105, Keeps Eq...

3 months ago 50

H.C. Wainwright Asserts Buy Rating on Immunitybio Inc. (IBRX) as Net Loss Narrows on Robust Product Revenue

H.C. Wainwright Asserts Buy Rating on Immunitybio ...

3 months ago 30

H.C. Wainwright Asserts Buy Rating on Immunitybio Inc. (IBRX) as Net Loss Narrows on Robust Product Revenue

H.C. Wainwright Asserts Buy Rating on Immunitybio ...

3 months ago 31

NextNRG Inc. (NXXT) in a Phase of Robust Growth amid Geographic Expansion

NextNRG Inc. (NXXT) in a Phase of Robust Growth am...

3 months ago 44

Vesta (VTMX) Reports 14% Revenue Growth and Raises Full-Year Guidance

Vesta (VTMX) Reports 14% Revenue Growth and Raises...

3 months ago 41

UBS Cuts Coca-Cola FEMSA (KOF) Target to $109, Maintains Buy Rating

UBS Cuts Coca-Cola FEMSA (KOF) Target to $109, Mai...

3 months ago 46

UBS Cuts Coca-Cola FEMSA (KOF) Target to $109, Maintains Buy Rating

UBS Cuts Coca-Cola FEMSA (KOF) Target to $109, Mai...

3 months ago 42

Wall Street Turns Bullish on Geron Corporation (GERN) amid Rytelo Sales Push Plans

Wall Street Turns Bullish on Geron Corporation (GE...

3 months ago 45

Wall Street Turns Bullish on Geron Corporation (GERN) amid Rytelo Sales Push Plans

Wall Street Turns Bullish on Geron Corporation (GE...

3 months ago 45

JPMorgan Reaffirms Buy Rating on Vista Energy (VIST), Keeps $68 Target

JPMorgan Reaffirms Buy Rating on Vista Energy (VIS...

3 months ago 45

JPMorgan Reaffirms Buy Rating on Vista Energy (VIST), Keeps $68 Target

JPMorgan Reaffirms Buy Rating on Vista Energy (VIS...

3 months ago 47

H.C. Wainwright Asserts Buy Stance as Gevo Inc. (GEVO) Q3 Results Impress on Robust Revenue Growth

H.C. Wainwright Asserts Buy Stance as Gevo Inc. (G...

3 months ago 44